Corticosteroid plus long-acting beta2-agonist prevent virus-associated upregulation of B7-H1/PD-L1 on airway epithelium

S. Hamano, K. Matsumoto, K. Kan-o, S. Fukuyama, Y. Asai, H. Inoue, Y. Nakanishi (Fukuoka, Kagoshima, Japan)

Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Session: Macrophages, mononuclear cells and viral infection
Session type: Thematic Poster Session
Number: 3878
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Hamano, K. Matsumoto, K. Kan-o, S. Fukuyama, Y. Asai, H. Inoue, Y. Nakanishi (Fukuoka, Kagoshima, Japan). Corticosteroid plus long-acting beta2-agonist prevent virus-associated upregulation of B7-H1/PD-L1 on airway epithelium. Eur Respir J 2013; 42: Suppl. 57, 3878

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
In vivo effects of corticosteroid plus long-acting beta2-agonist on the expression of B7-H1/PD-L1 in double-stranded RNA-induced lung inflammation
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014


Azithromycin augments rhinovirus-induced expression of IFNbeta and IFNλ1 in asthmatic bronchial epithelial cells by up-regulating RIG-I like receptors
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014

Differential effects of budesonide and fluticasone propionate on expression of lactotransferrin in airway epithelium
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014

Differential effects of budesonide and fluticasone propionate on bronchial epithelial barrier function
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014

Initial interaction of fluticasone propionate with ciliated respiratory epithelium
Source: International Congress 2016 – Pulmonary drug delivery
Year: 2016


Interleukin-22 downregulates double-stranded RNA-induced expression of B7-H1/PD-L1 on airway epithelial cells
Source: International Congress 2014 – Mechanistic studies of the airway epithelium
Year: 2014


COPD airway epithelium secretion attracts and activates neutrophils
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014

Glucocorticoids and indacaterol regulated gene expressions profiling in human bronchial epithelial cells
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013

Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells
Source: Eur Respir J 2012; 39: 439-445
Year: 2012



Anticholinergic treatment does not affect toll-like receptor 3-induced antiviral immune response in COPD bronchial epithelial cells
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015

Allergen exposed primary human bronchial epithelial cells have inhibited transport of salbutamol sulphate only when functional organic cation tranporters are present
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014


Fluticasone furoate maintains epithelial homeostasis via leptin/leptin receptor pathway in nasal cells
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013


Enhanced inflammatory gene expression in bronchial epithelial cells from asthmatic patients: Attenuation by a Brd4 mimic
Source: International Congress 2014 – Novel targets and drugs for asthma and COPD
Year: 2014


LATE-BREAKING ABSTRACT: Epigenetic inhibition of proliferation and inflammation in airway epithelium
Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment
Year: 2014

Differential effect of fluticasone on Poly(I:C) induced TSLP secretion by bronchial epithelial cells from asthmatic children
Source: International Congress 2016 – Mechanisms of disease
Year: 2016

Effects of formoterol on the molecular mechanisms of corticosteroid resistance in models with high oxidative stress
Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine
Year: 2014


S100 proteins induce MUC5AC production in airway epithelial cells
Source: International Congress 2014 – Mechanistic studies of the airway epithelium
Year: 2014

A novel inhaled PI3Kδ inhibitor, LAS194223 reduces allergen-induced airway inflammation in rat
Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis
Year: 2014

Tiotropium and fluticasone inhibit rhinovirus-induced mucin production via multiple mechanisms in differentiated airway epithelial cells
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020